B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
Table 4
SF-36 raw scores (scale 0–100) in 17 patients with clinically significant responses, and in 10 patients with no significant response, at baseline and during follow-upa.